Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
[Towards a nursing consultation in neurosexology].
Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
[Neuroimmunology: theoretical and clinical aspects].
16 Syndrome in a Patient With Multiple Sclerosis.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Perception of muscular effort in multiple sclerosis.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas.
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Epidemiology and clinical record of multiple sclerosis in selected countries - a systematic review.
Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation.
Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria.
Multiple sclerosis: CCSVI deconstructed and discarded.
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Sedentary behavior is associated with disability status and walking performance, but not cognitive function, in multiple sclerosis.
Pages
« first
‹ previous
…
500
501
502
503
504
505
506
507
508
…
next ›
last »